Text Size
36 studies found for:    " September 12, 2012":" October 12, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" September 12, 2012":" October 12, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df;   Drug: ritonavir + atazanavir + emtricitabine/tenofovir df
2 Not yet recruiting A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection
Condition: Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Intervention: Drug: No intervention
3 Active, not recruiting Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU
Condition: HIV
Interventions: Behavioral: Individual level;   Behavioral: Structural level;   Behavioral: Individual level standard of care;   Behavioral: Structural level standard of care
4 Active, not recruiting HIV Prevention for Injecting Drug Users in Kazakhstan
Conditions: HIV;   AIDS
Interventions: Behavioral: Couples Based HIV/STI Risk Reduction Intervention (CHSR);   Behavioral: Renaissance Wellness Promotion (WP)
5 Recruiting Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU);   Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU);   Biological: Ad35-GRIN (0.5mL)
6 Recruiting Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera
Condition: HIV-1 Infection
Intervention:
7 Recruiting First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers
Condition: HIV
Interventions: Drug: Maraviroc;   Drug: TVD 300/200 QD
8 Recruiting Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations
Condition: HIV Infection
Intervention: Behavioral: Integrated care centers
9 Recruiting Immune Reconstitution in HIV Disease (IREHIV)
Condition: HIV Infection
Interventions: Drug: vitamin D (cholecalciferol) and PBA (sodium phenylbutyrate);   Drug: Placebo tablets
10 Recruiting Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy
Conditions: HIV Infection;   Malaria
Intervention: Drug: Artemether/Lumefantrine (AL)
11 Recruiting Brain Imaging for HIV-Associated Thinking and Mood Disorders
Conditions: Human Immunodeficiency Virus;   Neurocognitive Impairment
Intervention:
12 Recruiting Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
Condition: HIV
Intervention: Drug: (FDC) ELV/COBI/FTC/TDF
13 Not yet recruiting A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection
Conditions: Infection;   HIV
Intervention: Drug: Truvada and Isentress
14 Not yet recruiting Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin
Conditions: AIDS;   Tuberculosis
Intervention: Drug: Lopinavir/ritonavir and ritonavir
15 Recruiting Online Social Networks for HIV Prevention Among African American and Latino MSM
Condition: HIV
Intervention: Behavioral: HIV knowledge Intervention
16 Active, not recruiting Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Conditions: Cardiovascular Diseases;   HIV
Intervention:
17 Active, not recruiting Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz
Conditions: Hyperlipidemia;   HIV
Interventions: Drug: Pitavastatin;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Efavirenz
18 Active, not recruiting Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland
Conditions: Pregnancy;   HIV
Intervention: Procedure: Integrated FP/PNC service delivery
19 Recruiting Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
Conditions: HIV;   Hypercholesterolemia;   Dyslipidemia
Intervention:
20 Recruiting Observational Study of Male Circumsition Using PrePex Device
Condition: HIV
Intervention: Device: PrePex device for male circumcision
To Top

Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results
† Indicates status has not been verified in more than two years